Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses

被引：1
|
作者：
Li, Zijun [1 ,2 ]
Lee, Joo-Eun [2 ]
Cho, Namki [2 ]
Yoo, Hee Min [1 ,3 ]
机构：
[1] Korea Res Inst Stand & Sci KRISS, Biometrol Grp, Daejeon 34113, South Korea
[2] Chonnam Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Gwangju 61186, South Korea
[3] Univ Sci & Technol UST, Dept Precis Measurement, Daejeon 34113, South Korea
来源：
HELIYON | 2023年 / 9卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
Natural products; SARS-CoV-2; Pseudotyped viruses; Antiviral activity; Reactive oxygen species; USNIC ACID; HOSPITALIZED-PATIENTS; USNEA-BARBATA; IN-VITRO; TOCILIZUMAB; ANTIFUNGAL; EXTRACTS;
D O I：
10.1016/j.heliyon.2023.e21742
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The escalating pandemic brought about by the novel SARS-CoV-2 virus is threatening global health, and thus, it is necessary to develop effective antiviral drugs. Usenamine A is a dibenzofuran derivative separated from lichen Usnea diffracta showing broad-spectrum activity against different viruses. We evaluate that usenamine A has antiviral effects against novel SARS-CoV-2 Delta variant pseudotyped viruses (PVs) in A549 cells. In addition, usenamine A significantly suppresses SARS-CoV-2 PV-induced mitochondrial depolarization, elevated reactive oxygen species (ROS) levels, apoptosis, and inflammation. Usenamine A also causes the SARS-CoV-2 spike protein to become less stable. Thus, usenamine A shows potential as an antiviral drug that can provide protection against COVID-19.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
    Chan, Michele
    Linn, Me Me Nay
    O'Hagan, Thomas
    Guerra-Assuncao, Jose Afonso
    Lackenby, Angie
    Workman, Sarita
    Dacre, Anna
    Burns, Siobhan O.
    Breuer, Judith
    Hart, Jennifer
    Tadros, Susan
    Lowe, David M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1083 - 1092
  • [22] SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity
    Jaycox, Jillian R. R.
    Lucas, Carolina
    Yildirim, Inci
    Dai, Yile
    Wang, Eric Y. Y.
    Monteiro, Valter
    Lord, Sandra
    Carlin, Jeffrey
    Kita, Mariko
    Buckner, Jane H. H.
    Ma, Shuangge
    Campbell, Melissa
    Ko, Albert
    Omer, Saad
    Lucas, Carrie L. L.
    Speake, Cate
    Iwasaki, Akiko
    Ring, Aaron M. M.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [23] Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity
    Lineburg, Katie Eireann
    Crooks, Pauline
    Raju, Jyothy
    Texier, Laetitia Le
    Khaledi, Panteha
    Berry, Kiana
    Swaminathan, Srividhya
    Panikkar, Archana
    Rehan, Sweera
    Guppy-Coles, Kristyan
    Neller, Michelle Anne
    Khanna, Rajiv
    Smith, Corey
    ISCIENCE, 2023, 26 (12)
  • [24] SARS-CoV-2 infection in pregnant female mouse featured as delayed anti-viral response
    Liu, Lu
    Zhu, GuoHua
    Du, MeiRong
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2023, 156
  • [25] Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
    Michele Chan
    Me Me Nay Linn
    Thomas O’Hagan
    José Afonso Guerra-Assunção
    Angie Lackenby
    Sarita Workman
    Anna Dacre
    Siobhan O. Burns
    Judith Breuer
    Jennifer Hart
    Susan Tadros
    David M. Lowe
    Journal of Clinical Immunology, 2023, 43 : 1083 - 1092
  • [26] Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
    Li Runfeng
    Hou Yunlong
    Huang Jicheng
    Pan Weiqi
    Ma Qinhai
    Shi Yongxia
    Li Chufang
    Zhao Jin
    Jia Zhenhua
    Jiang Haiming
    Zheng Kui
    Huang Shuxiang
    Dai Jun
    Li Xiaobo
    Hou Xiaotao
    Wang Lin
    Zhong Nanshan
    Yang Zifeng
    PHARMACOLOGICAL RESEARCH, 2020, 156
  • [27] Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin
    Du, Xiaohong
    Zuo, Xiangyang
    Meng, Fang
    Han, Chenfeng
    Ouyang, Wei
    Han, Yu
    Gu, Yayun
    Zhao, Xin
    Xu, Feng
    Qin, Frank Xiaofeng
    CELL PROLIFERATION, 2021, 54 (01)
  • [28] Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
    Mohammed Ghalib Enayathullah
    Yash Parekh
    Sarena Banu
    Sushma Ram
    Ramakrishnan Nagaraj
    Bokara Kiran Kumar
    Mohammed M. Idris
    Scientific Reports, 12
  • [29] Keynote Lecture "Anti-viral Drug Discovery for Severe Acute Respiratory Syndrome (SARS-CoV-2)"
    Quinn, R.
    Liu, M.
    Gu, Y.
    Mak, T.
    Belden, E.
    PLANTA MEDICA, 2022, 88 (15) : 1403 - 1403
  • [30] Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity
    Maity, Subhasish
    Santra, Ayantika
    Hebbani, Ananda Vardhan
    Pulakuntla, Swetha
    Chatterjee, Ankita
    Badri, Kameswara Rao
    Reddy, Vaddi Damodara
    GENE, 2023, 881
12345